TrademarkDir
PROSTATAK
DEAD

Serial Number

86233194

Owner

Advantagene, Inc.

First Use Date

Apr 9, 2004

Filing Date

Mar 26, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PROSTATAK Trademark

Serial Number: 86233194 • Registration: 4741947

PROSTATAK is a trademark filed by Advantagene, Inc. on March 26, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Advantagene, Inc. (4 trademarks)

440 Lexington Street
Auburndale, MA 02466

Entity Type: 03

Trademark Details

Filing Date

March 26, 2014

Registration Date

May 26, 2015

First Use Anywhere

April 9, 2004

First Use in Commerce

April 9, 2004

Published for Opposition

March 10, 2015

Cancellation Date

December 3, 2021

Goods & Services

Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 3, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 26, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
May 26, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2015 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 2, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2015 CRFA
ASSIGNED TO LIE
Jan 5, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 30, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 27, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2014 NWOS
NEW APPLICATION ENTERED
Mar 29, 2014 NWAP

Related Trademarks

More from this Owner

CANDEL THERAPEUTICS

CANDEL THERAPEUTICS

VIRAFIR

VIRAFIR

VIRAFIR

VIRAFIR

ADVANTAGENE

ADVANTAGENE

ADVANTAGENE

ADVANTAGENE

ADVANTAGENE

ADVANTAGENE